Bio-Rad Laboratories: Q2 Earnings Insights

Bio-Rad Laboratories BIO reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Bio-Rad Laboratories beat estimated earnings by 20.71%, reporting an EPS of $3.38 versus an estimate of $2.8.

Revenue was down $24.83 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $1.54 which was followed by a 0.2% drop in the share price the next day.

Here’s a look at Bio-Rad Laboratories’s past performance:








Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 3.40 2.85 2.44 2.66
EPS Actual 4.94 3.21 3.71 3.54
Revenue Estimate 675.10M 731.98M 661.87M 631.78M
Revenue Actual 700.06M 732.77M 715.20M 715.93M








Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 3.40 2.85 2.44 2.66
EPS Actual 4.94 3.21 3.71 3.54
Revenue Estimate 675.10M 731.98M 661.87M 631.78M
Revenue Actual 700.06M 732.77M 715.20M 715.93M

To track all earnings releases for Bio-Rad Laboratories visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.



Image and article originally from www.benzinga.com. Read the original article here.